###BASE_URL###

GENET-news

To stay informed you can subscribe to the GENET-news list.

 

2009-07-06 |

Blue GE roses approved for commercial release in Australia

Australia’s Gene Technology Regulator has granted a licence to Florigene for commercial release of a genetically modified Hybrid Tea rose which expresses genes for the colour blue. [...] Six years after it was founded in Melbourne in 1986, Florigene gained patents over use of a petunia gene which imparts blue flower colour. In 1994 it successfully implanted the gene into carnations to create a GM range which has been commercially available worldwide for some years. In 2003 the company was acquired by the Suntory group of companies but its research is still conducted in Melbourne.

Overview

News

2009-07-06 |

Blue GE roses approved for commercial release in Australia

Australia’s Gene Technology Regulator has granted a licence to Florigene for commercial release of a genetically modified Hybrid Tea rose which expresses genes for the colour blue. [...] Six years after it was founded in Melbourne in 1986, Florigene gained patents over use of a petunia gene which imparts blue flower colour. In 1994 it successfully implanted the gene into carnations to create a GM range which has been commercially available worldwide for some years. In 2003 the company was acquired by the Suntory group of companies but its research is still conducted in Melbourne.

Home: GENET

GENET-news & GENET-forum

GENET-news is providing a daily news service on a range of topics regarding genetic engineering. We are screening the worldwide English news, press releases and other publications to provide you with a strategic selection of information. GENET-news enables you to stay informed about all aspects of the global controversy around GE technologies and GE organisms. You can subscribe by  email.

The GENET-forum list provides you with additional background information and more voluminous reports. It is only open for GENET members. Please contact the  coordinator for membership and subscription.